1. Introduction
2. Hypothesis: Why Stem Cells Could Be a Possible Solution
3. Present Procedure and Future Perspectives and Limitations
4. Conclusions
Author Contributions
Funding
Conflicts of Interest
Abbreviations
ATII | Alveolar Type II |
DCs | Dendritic Cells |
ESCs | Embryonic Stem Cells |
GVHD | Graft-Versus-Host Disease |
iPSCs | Induced Pluripotent Stem Cells |
MHC I | Co-Stimulatory Factors CD-80 and CD-86 |
MSCs | Mesenchymal Stem Cells |
M2 | Macrophages Type 2 |
NK | Natural Killer |
SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
γ/δ T Cells | Gamma and Delta T Lymphocytes |
References
- Ludvigsson, J.F. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatr. 2020, 109, 1088–1095. [Google Scholar] [CrossRef]
- Lee, P.I.; Hu, Y.L.; Chen, P.Y.; Huang, Y.C.; Hsueh, P.R. Are children less susceptible to COVID-19? J. Microbiol. Immunol. Infect. 2020, 53, 371–372. [Google Scholar] [CrossRef]
- Balzanelli, G.M.; Distratis, P.; Catucci, O.; Amatulli, F.; Cefalo, A.; Lazzaro, R.; Aityan, K.S.; Dalagni, G.; Nico, A.; De Michele, A.; et al. Clinical and diagnostic findings in COVID-19 and non-COVID-19 patients, an original research from SG Moscati Hospital in Taranto City. J. Biol. Regul. Homeost. Agents 2021, 35, 105–117. [Google Scholar]
- Charitos, I.A.; Ballini, A.; Bottalico, L.; Cantore, S.; Passarelli, P.C.; Inchingolo, F.; D’Addona, A.; Santacroce, L. Special features of SARS-CoV-2 in daily practice. World J. Clin. Cases 2020, 8, 3920–3933. [Google Scholar] [CrossRef] [PubMed]
- Santacroce, L.; Charitos, I.A.; Ballini, A.; Inchingolo, F.; Luperto, P.; De Nitto, E.; Topi, S. The Human Respiratory System and its Microbiome at a Glimpse. Biology 2020, 9, 318. [Google Scholar] [CrossRef] [PubMed]
- Cazzolla, A.P.; Lovero, R.; Lo Muzio, L.; Testa, N.F.; Schirinzi, A.L.; Palmieri, G.; Pozzessere, P.; Procacci, V.; Di Comite, M.; Ciavarella, D.; et al. Taste and smell disorders in COVID-19 patients: Role of Interleukin-6. ACS Chem. Neurosci. 2020, 11, 2774–2781. [Google Scholar] [CrossRef] [PubMed]
- Klimczak, A. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19. World J. Stem Cells 2020, 12, 1013–1022. [Google Scholar] [CrossRef]
- Cantore, S.; Crincoli, V.; Boccaccio, A.; Uva, A.E.; Fiorentino, M.; Monno, G.; Bollero, P.; Derla, C.; Fabiano, F.; Ballini, A.; et al. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaf-folds. Endocr. Metab. Immune. Disord. Drug Targets 2018, 18, 466–469. [Google Scholar] [CrossRef]
- Ballini, A.; Boccaccio, A.; Saini, R.; Van Pham, P.; Tatullo, M. Dental-Derived Stem Cells and Their Secretome and Interactions with Bioscaffolds/Biomaterials in Regenerative Medicine: From the In Vitro Research to Translational Applications. Stem. Cells. Int. 2017, 2017, 6975251. [Google Scholar] [CrossRef] [PubMed]
- O’Rourke, B.; Nguyen, S.; Tilles, A.W.; Bynum, J.A.; Cap, A.P.; Parekkadan, B.; Barcia, R.N. Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application. Stem Cells Transl. Med. 2021. [Google Scholar] [CrossRef]
- Cantore, S.; Ballini, A. Coronavirus Disease 2019 (COVID-19) pandemic burst and its relevant consequences in dental practice. Open Dent. J. 2020, 14, 111–112. [Google Scholar] [CrossRef]
- Maremanda, K.P.; Sundar, I.K.; Li, D.; Rahman, I. Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis. Front. Pharmacol. 2020, 11, 584637. [Google Scholar] [CrossRef] [PubMed]
- Shimamoto, A.; Yokote, K.; Tahara, H. Werner Syndrome-specific induced pluripotent stem cells: Recovery of telomere function by reprogramming. Front. Genet. 2015, 6, 10. [Google Scholar] [CrossRef][Green Version]
- Gargiulo, C.; Pham, H.V.; Thuy Hai, N.; Nguyen, K.; Phuc, P.; Abe, K.; Flores, V.; Shiffman, M. Isolation and Characterization of Multipotent and Pluripotent Stem Cells from Human Peripheral Blood. Stem Cell Discov. 2015, 5, 19–32. [Google Scholar] [CrossRef][Green Version]
- Gargiulo, C.; Pham, H.V.; Nguyen, C.D.K.; Trieu, V.L.H.; Duy, H.T.; Abe, K.; Aityan, S. Autologous Peripheral Blood Stem Cells Increase the Telomere Length in Patient: A Case Report of 13 Patients. J. Stem Cell Res. Ther. 2016, 6, 1–6. [Google Scholar] [CrossRef][Green Version]
- Monno, R.; De Vito, D.; Losito, G.; Sibilio, G.; Costi, A.; Fumarola, L.; D’Aprile, A.; Marcuccio, P. Chlamydia pneumoniae in community-acquired pneumonia: Seven years of experience. J. Infect. 2002, 45, 135–138. [Google Scholar] [CrossRef]
- Brindicci, G.; Picciarelli, C.; Fumarola, L.; Carbonara, S.; Stano, F.; Ciracì, E.; Gramiccia, M.; Sannella, A.R.; Milella, M.; De Vito, D.; et al. Amoebic hepatic abscesses in an HIV-positive patient. AIDS Patient Care STDS 2006, 20, 606–611. [Google Scholar] [CrossRef] [PubMed]
- Pham, V.H.; Gargiulo, I.C.; Nguyen, K.C.D.; Le, S.H.; Tran, D.K.; Nguyen, Q.V.; Pham, H.T.; Aityan, S.; Pham, S.T.; Cantore, S.; et al. Rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronaviridae family members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: A translational research and cooperation between the Phan Chau Trinh University in Vietnam and University of Bari “Aldo Moro” in Italy. Eur. Rev. Med. Pharmacol. Sci. 2020, 24, 7173–7191. [Google Scholar]
- Hoffmann, C.; Casado, J.L.; Härter, G.; Vizcarra, P.; Moreno, A.; Cattaneo, D.; Meraviglia, P.; Spinner, C.D.; Schabaz, F.; Grunwald, S.; et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2020. [Google Scholar] [CrossRef]
- Ballini, A.; Dipalma, G.; Isacco, C.G.; Boccellino, M.; Di Domenico, M.; Santacroce, L.; Nguyễn, K.C.D.; Scacco, S.; Calvani, M.; Boddi, A.; et al. Oral Microbiota and Immune System Crosstalk: A Translational Research. Biology 2020, 9, 131. [Google Scholar] [CrossRef] [PubMed]
- Montagnier, L.; Aïssa, J.; Lavallée, C.; Mbamy, M.; Varon, J.; Chenal, H. Electromagnetic detection of HIV DNA in the blood of AIDS patients treated by antiretroviral therapy. Interdiscip. Sci. 2009, 1, 245–253. [Google Scholar] [CrossRef] [PubMed]
- Bedin, A.S.; Makinson, A.; Picot, M.C.; Mennechet, F.; Malergue, F.; Pisoni, A.; Nyiramigisha, E.; Montagnier, L.; Bollore, K.; Debiesse, S.; et al. Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19. J. Infect. Dis. 2020, jiaa724. [Google Scholar] [CrossRef]
- Gargiulo, C.; Pham, V.; Thuy Hai, N.; Nguyen, K.; Duong Kim, N.; Nguyen Van, T.; Tuan, A.; Abe, K.; Flores, V.; Shiffman, M. Autologous Peripheral Blood Stem Cells and γ/δ T Cells May Improve Immunity in Treating Secondary Bacteremic Infection in HIV Infected Patient. Stem Cell Dis. 2015, 5, 48–61. [Google Scholar] [CrossRef][Green Version]
- Bordea, I.R.; Xhajanka, E.; Candrea, S.; Bran, S.; Onis, F.; Inchingolo, A.D.; Malcangi, G.; Pham, V.H.; Inchingolo, A.M.; Scarano, A.; et al. Coronavirus (SARS-CoV-2) pandemic: Emerging and Future Challenges for Dental Practitioners. Mircoorganisms. 2020, 8, 1704. [Google Scholar] [CrossRef]
- Tufan, A.C. Mesenchymal stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines. Curr. Stem Cell Res. Ther. 2020. [Google Scholar] [CrossRef]
- Harrell, C.R.; Jovicic, B.P.; Djonov, V.; Volarevic, V. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome. Anal. Cell. Pathol. 2020, 2020, 1939768. [Google Scholar] [CrossRef] [PubMed]
- Coelho, A.; Alvites, R.D.; Branquinho, M.V.; Guerreiro, S.G.; Maurício, A.C. Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research. Front. Cell Dev. Biol. 2020, 8, 602647. [Google Scholar] [CrossRef]
- Charitos, I.A.; Del Prete, R.; Inchingolo, F.; Mosca, A.; Carretta, D.; Ballini, A.; Santacroce, L. What we have learned for the future about COVID-19 and healthcare management of it? Acta Biomed. 2020, 91, e2020126. [Google Scholar]


Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).